Shares Outstanding: 21.91M
The shares outstanding is 21.91M. It is below its 12-month average by 2.13% (22.39M).
NRC Shares Outstanding
Reported quarterly weighted average share count; no daily interpolation.
NRC Average Shares Outstanding Chart
NRC Current vs Average Shares Outstanding Chart
NRC Shares Outstanding Metrics
SHARES OUTSTANDING
21.91M
SHARES OUTSTANDING AVG TTM
22.39M
SHARES OUTSTANDING AVG 3Y
23.51M
SHARES OUTSTANDING AVG 5Y
24.21M
SHARES OUTSTANDING AVG 10Y
25.07M
SHARES OUTSTANDING AVG 15Y
24.70M
SHARES OUTSTANDING AVG 20Y
18.42M
CURRENT VS TTM AVG
-2.13%
CURRENT VS 3Y AVG
-6.80%
CURRENT VS 5Y AVG
-9.50%
CURRENT VS 10Y AVG
-12.61%
CURRENT VS 15Y AVG
-11.30%
CURRENT VS 20Y AVG
+18.96%
Share Structure
Shares Outstanding
22.38M
Float Shares
N/A
Stock Price
$20.81
Market Cap
$0.5B
Quarterly Shares Outstanding History
| Period | Weighted Average Shares | QoQ Change |
|---|---|---|
| Q1 2026 | 21.91M | +0.48% |
| Q4 2025 | 21.81M | -3.47% |
| Q3 2025 | 22.59M | -0.30% |
| Q2 2025 | 22.66M | -1.38% |
| Q1 2025 | 22.97M | -1.68% |
| Q4 2024 | 23.37M | -1.60% |
| Q3 2024 | 23.75M | -0.71% |
| Q2 2024 | 23.91M | -0.20% |
| Q1 2024 | 23.96M | -2.38% |
| Q4 2023 | 24.55M | -0.60% |
| Q3 2023 | 24.70M | -0.08% |
| Q2 2023 | 24.72M | -0.09% |
| Q1 2023 | 24.74M | -0.15% |
| Q4 2022 | 24.77M | -0.29% |
| Q3 2022 | 24.85M | -1.44% |
| Q2 2022 | 25.21M | -0.71% |
| Q1 2022 | 25.39M | -0.81% |
| Q4 2021 | 25.60M | -0.21% |
| Q3 2021 | 25.65M | +0.02% |
| Q2 2021 | 25.64M | -0.09% |
| Q1 2021 | 25.67M | -0.06% |
| Q4 2020 | 25.68M | -0.08% |
| Q3 2020 | 25.70M | +0.09% |
| Q2 2020 | 25.68M | -0.17% |
| Q1 2020 | 25.73M | +0.04% |
| Q4 2019 | 25.71M | -0.10% |
| Q3 2019 | 25.74M | +0.61% |
| Q2 2019 | 25.59M | +0.30% |
| Q1 2019 | 25.51M | -0.10% |
| Q4 2018 | 25.53M | +0.03% |
| Q3 2018 | 25.53M | -10.33% |
| Q2 2018 | 28.47M | +11.78% |
| Q1 2018 | 25.47M | -0.00% |
| Q4 2017 | 25.47M | +0.43% |
| Q3 2017 | 25.36M | +0.97% |
| Q2 2017 | 25.12M | +1.19% |
| Q1 2017 | 24.82M | +0.54% |
| Q4 2016 | 24.69M | +0.26% |
| Q3 2016 | 24.62M | +0.27% |
| Q2 2016 | 24.56M | -0.02% |
| Q1 2016 | 24.56M | +0.42% |
| Q4 2015 | 24.46M | +0.00% |
| Q3 2015 | 24.46M | -0.38% |
| Q2 2015 | 24.55M | -0.02% |
| Q1 2015 | 24.56M | -0.19% |
| Q4 2014 | 24.60M | +0.13% |
| Q3 2014 | 24.57M | -0.17% |
| Q2 2014 | 24.61M | -0.26% |
| Q1 2014 | 24.68M | +0.10% |
| Q4 2013 | 24.65M | +0.11% |
| Q3 2013 | 24.63M | +0.10% |
| Q2 2013 | 24.60M | +100.22% |
| Q1 2013 | 12.29M | +75.88% |
| Q4 2012 | 6.99M | +0.56% |
| Q3 2012 | 6.95M | +0.06% |
| Q2 2012 | 6.94M | +0.52% |
| Q1 2012 | 6.91M | +2.80% |
| Q4 2011 | 6.72M | -1.91% |
| Q3 2011 | 6.85M | -0.07% |
| Q2 2011 | 6.86M | +0.68% |
| Q1 2011 | 6.81M | +2.33% |
| Q4 2010 | 6.65M | -1.09% |
| Q3 2010 | 6.73M | -0.07% |
| Q2 2010 | 6.73M | +0.31% |
| Q1 2010 | 6.71M | +1.07% |
| Q4 2009 | 6.64M | -1.41% |
| Q3 2009 | 6.74M | +0.01% |
| Q2 2009 | 6.73M | +0.31% |
| Q1 2009 | 6.71M | +1.20% |
| Q4 2008 | 6.63M | -2.49% |
| Q3 2008 | 6.80M | +0.15% |
| Q2 2008 | 6.79M | -2.55% |
| Q1 2008 | 6.97M | +2.24% |
| Q4 2007 | 6.82M | -2.79% |
| Q3 2007 | 7.01M | +0.16% |
| Q2 2007 | 7.00M | +0.54% |
| Q1 2007 | 6.96M | +1.79% |
| Q4 2006 | 6.84M | -2.06% |
| Q3 2006 | 6.99M | +0.22% |
| Q2 2006 | 6.97M | +0.75% |
| Q1 2006 | 6.92M | +1.45% |
| Q4 2005 | 6.82M | -3.36% |
| Q3 2005 | 7.06M | -1.70% |
| Q2 2005 | 7.18M | -0.33% |
| Q1 2005 | 7.20M | +0.74% |
| Q4 2004 | 7.15M | -1.03% |
| Q3 2004 | 7.22M | -0.82% |
| Q2 2004 | 7.28M | -0.95% |
| Q1 2004 | 7.35M | +1.33% |
| Q4 2003 | 7.26M | -1.01% |
| Q3 2003 | 7.33M | +0.38% |
| Q2 2003 | 7.30M | +0.09% |
| Q1 2003 | 7.30M | +0.65% |
| Q4 2002 | 7.25M | +0.68% |
| Q3 2002 | 7.20M | +0.09% |
| Q2 2002 | 7.19M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Shares Outstanding Formula & Definition
Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shares Outstanding FAQ
- What is the shares outstanding for National Research Corporation (NRC)?
- The shares outstanding for NRC stock is 21.91M.
- What is the TTM average shares outstanding for National Research Corporation (NRC)?
- The TTM average shares outstanding for NRC stock is 22.39M.
- What is the 3Y average shares outstanding for National Research Corporation (NRC)?
- The 3Y average shares outstanding for NRC stock is 23.51M.
- What is the 5Y average shares outstanding for National Research Corporation (NRC)?
- The 5Y average shares outstanding for NRC stock is 24.21M.
- What is the 10Y average shares outstanding for National Research Corporation (NRC)?
- The 10Y average shares outstanding for NRC stock is 25.07M.
- What is the 15Y average shares outstanding for National Research Corporation (NRC)?
- The 15Y average shares outstanding for NRC stock is 24.70M.
- What is the 20Y average shares outstanding for National Research Corporation (NRC)?
- The 20Y average shares outstanding for NRC stock is 18.42M.
NRC Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2026-03-31 | 21.91M |
| 2025-12-31 | 21.81M |
| 2025-09-30 | 22.59M |
| 2025-06-30 | 22.66M |
| 2025-03-31 | 22.97M |
| 2024-12-31 | 23.37M |
| 2024-09-30 | 23.75M |
| 2024-06-30 | 23.91M |
| 2024-03-31 | 23.96M |
| 2023-12-31 | 24.55M |
| 2023-09-30 | 24.70M |
| 2023-06-30 | 24.72M |
| 2023-03-31 | 24.74M |
| 2022-12-31 | 24.77M |
| 2022-09-30 | 24.85M |
| 2022-06-30 | 25.21M |
| 2022-03-31 | 25.39M |
| 2021-12-31 | 25.60M |
| 2021-09-30 | 25.65M |
| 2021-06-30 | 25.64M |
| 2021-03-31 | 25.67M |
| 2020-12-31 | 25.68M |
| 2020-09-30 | 25.70M |
| 2020-06-30 | 25.68M |
| 2020-03-31 | 25.73M |
| 2019-12-31 | 25.71M |
| 2019-09-30 | 25.74M |
| 2019-06-30 | 25.59M |
| 2019-03-31 | 25.51M |
| 2018-12-31 | 25.53M |
| 2018-09-30 | 25.53M |
| 2018-06-30 | 28.47M |
| 2018-03-31 | 25.47M |
| 2017-12-31 | 25.47M |
| 2017-09-30 | 25.36M |
| 2017-06-30 | 25.12M |
| 2017-03-31 | 24.82M |
| 2016-12-31 | 24.69M |
| 2016-09-30 | 24.62M |
| 2016-06-30 | 24.56M |
| 2016-03-31 | 24.56M |
| 2015-12-31 | 24.46M |
| 2015-09-30 | 24.46M |
| 2015-06-30 | 24.55M |
| 2015-03-31 | 24.56M |
| 2014-12-31 | 24.60M |
| 2014-09-30 | 24.57M |
| 2014-06-30 | 24.61M |
| 2014-03-31 | 24.68M |
| 2013-12-31 | 24.65M |
| 2013-09-30 | 24.63M |
| 2013-06-30 | 24.60M |
| 2013-03-31 | 12.29M |
| 2012-12-31 | 6.99M |
| 2012-09-30 | 6.95M |
| 2012-06-30 | 6.94M |
| 2012-03-31 | 6.91M |
| 2011-12-31 | 6.72M |
| 2011-09-30 | 6.85M |
| 2011-06-30 | 6.86M |
| 2011-03-31 | 6.81M |
| 2010-12-31 | 6.65M |
| 2010-09-30 | 6.73M |
| 2010-06-30 | 6.73M |
| 2010-03-31 | 6.71M |
| 2009-12-31 | 6.64M |
| 2009-09-30 | 6.74M |
| 2009-06-30 | 6.73M |
| 2009-03-31 | 6.71M |
| 2008-12-31 | 6.63M |
| 2008-09-30 | 6.80M |
| 2008-06-30 | 6.79M |
| 2008-03-31 | 6.97M |
| 2007-12-31 | 6.82M |
| 2007-09-30 | 7.01M |
| 2007-06-30 | 7.00M |
| 2007-03-31 | 6.96M |
| 2006-12-31 | 6.84M |
| 2006-09-30 | 6.99M |
| 2006-06-30 | 6.97M |
| 2006-03-31 | 6.92M |
| 2005-12-31 | 6.82M |
| 2005-09-30 | 7.06M |
| 2005-06-30 | 7.18M |
| 2005-03-31 | 7.20M |
| 2004-12-31 | 7.15M |
| 2004-09-30 | 7.22M |
| 2004-06-30 | 7.28M |
| 2004-03-31 | 7.35M |
| 2003-12-31 | 7.26M |
| 2003-09-30 | 7.33M |
| 2003-06-30 | 7.30M |
| 2003-03-31 | 7.30M |
| 2002-12-31 | 7.25M |
| 2002-09-30 | 7.20M |
| 2002-06-30 | 7.19M |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green